Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Heart mapping study seeks clues to dangerous rhythms in genetic AF patients

NCT ID NCT06647459

First seen Feb 19, 2026 · Last updated Jun 22, 2026 · Updated 16 times

Summary

This study aimed to understand why some people with genetic early-onset atrial fibrillation (AF) are at risk for a dangerous heart rhythm called ventricular tachycardia (VT). Researchers used special heart mapping during a standard AF ablation procedure in 32 adults. The goal was to compare heart tissue and electrical patterns between those with a specific genetic variant (TTN) and those without, to better predict VT risk.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ATRIAL FIBRILLATION are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Vanderbilt University Medical Center

    Nashville, Tennessee, 37232, United States

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to

If successful, this could help doctors better predict dangerous heart rhythms in people with certain genetic forms of atrial fibrillation.

What could go wrong

This trial was terminated early with only 32 participants, so results may be limited. It is an observational mapping study, not a treatment test.

Conditions

The condition(s) this trial relates to.

atrial fibrillation ventricular tachycardia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.